ESTRIMA SPA (BIRO.MI) Fundamental Analysis & Valuation

BIT:BIRO • IT0005468191

Current stock price

0.201 EUR
0 (-1.47%)
Last:

This BIRO.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BIRO.MI Profitability Analysis

1.1 Basic Checks

  • In the past year BIRO has reported negative net income.
  • In the past year BIRO had a positive cash flow from operations.
  • In the past 5 years BIRO always reported negative net income.
  • In the past 5 years BIRO reported 4 times negative operating cash flow.
BIRO.MI Yearly Net Income VS EBIT VS OCF VS FCFBIRO.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • BIRO's Return On Assets of -9.93% is on the low side compared to the rest of the industry. BIRO is outperformed by 70.97% of its industry peers.
  • BIRO has a worse Return On Equity (-41.27%) than 70.97% of its industry peers.
Industry RankSector Rank
ROA -9.93%
ROE -41.27%
ROIC N/A
ROA(3y)-17.96%
ROA(5y)N/A
ROE(3y)-73.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BIRO.MI Yearly ROA, ROE, ROICBIRO.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • Looking at the Gross Margin, with a value of 20.96%, BIRO is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BIRO has grown nicely.
  • BIRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y4.17%
BIRO.MI Yearly Profit, Operating, Gross MarginsBIRO.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BIRO.MI Health Analysis

2.1 Basic Checks

  • BIRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BIRO has about the same amount of shares outstanding.
  • BIRO has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BIRO has a worse debt to assets ratio.
BIRO.MI Yearly Shares OutstandingBIRO.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2021 2022 2023 2024 5M 10M
BIRO.MI Yearly Total Debt VS Total AssetsBIRO.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • BIRO has an Altman-Z score of 0.56. This is a bad value and indicates that BIRO is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.56, BIRO is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
  • BIRO has a debt to FCF ratio of 3.90. This is a good value and a sign of high solvency as BIRO would need 3.90 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 3.90, BIRO belongs to the best of the industry, outperforming 83.87% of the companies in the same industry.
  • BIRO has a Debt/Equity ratio of 0.97. This is a neutral value indicating BIRO is somewhat dependend on debt financing.
  • The Debt to Equity ratio of BIRO (0.97) is worse than 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 3.9
Altman-Z 0.56
ROIC/WACCN/A
WACC7.14%
BIRO.MI Yearly LT Debt VS Equity VS FCFBIRO.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that BIRO should not have too much problems paying its short term obligations.
  • BIRO's Current ratio of 1.26 is in line compared to the rest of the industry. BIRO outperforms 58.06% of its industry peers.
  • BIRO has a Quick Ratio of 1.26. This is a bad value and indicates that BIRO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.77, BIRO is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.77
BIRO.MI Yearly Current Assets VS Current LiabilitesBIRO.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BIRO.MI Growth Analysis

3.1 Past

  • BIRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.03%, which is quite impressive.
  • The Revenue for BIRO has decreased by -22.99% in the past year. This is quite bad
  • BIRO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.21% yearly.
EPS 1Y (TTM)82.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.34%
Revenue 1Y (TTM)-22.99%
Revenue growth 3Y54.95%
Revenue growth 5Y40.21%
Sales Q2Q%-33.9%

3.2 Future

  • Based on estimates for the next years, BIRO will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.35% on average per year.
  • The Revenue is expected to grow by 3.69% on average over the next years.
EPS Next Y50%
EPS Next 2Y22.47%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue Next Year-18.57%
Revenue Next 2Y-7.3%
Revenue Next 3Y0%
Revenue Next 5Y3.69%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BIRO.MI Yearly Revenue VS EstimatesBIRO.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
BIRO.MI Yearly EPS VS EstimatesBIRO.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

Find the best growth stocksShow best growing peers

2

4. BIRO.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BIRO. In the last year negative earnings were reported.
  • Also next year BIRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIRO.MI Price Earnings VS Forward Price EarningsBIRO.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BIRO is valued a bit more expensive than the industry average as 61.29% of the companies are valued more cheaply.
  • BIRO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BIRO is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.37
EV/EBITDA 24.05
BIRO.MI Per share dataBIRO.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • BIRO's earnings are expected to grow with 19.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.47%
EPS Next 3Y19.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BIRO.MI Dividend Analysis

5.1 Amount

  • BIRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BIRO.MI Fundamentals: All Metrics, Ratios and Statistics

ESTRIMA SPA

BIT:BIRO (10/1/2025, 7:00:00 PM)

0.201

0 (-1.47%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners3.94%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.98M
Revenue(TTM)33.33M
Net Income(TTM)-2.14M
Analysts37.78
Price Target0.2 (-0.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-0.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-25.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF 3.37
P/OCF 2.69
P/B 1.15
P/tB 1.32
EV/EBITDA 24.05
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.06
FCFY29.66%
OCF(TTM)0.07
OCFY37.19%
SpS1.12
BVpS0.17
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -9.93%
ROE -41.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.96%
FCFM 5.32%
ROA(3y)-17.96%
ROA(5y)N/A
ROE(3y)-73.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y4.17%
F-Score5
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 3.9
Debt/EBITDA 14.53
Cap/Depr 34.03%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion 639.13%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.77
Altman-Z 0.56
F-Score5
WACC7.14%
ROIC/WACCN/A
Cap/Depr(3y)101.11%
Cap/Depr(5y)147.83%
Cap/Sales(3y)4.41%
Cap/Sales(5y)7.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.34%
EPS Next Y50%
EPS Next 2Y22.47%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.99%
Revenue growth 3Y54.95%
Revenue growth 5Y40.21%
Sales Q2Q%-33.9%
Revenue Next Year-18.57%
Revenue Next 2Y-7.3%
Revenue Next 3Y0%
Revenue Next 5Y3.69%
EBIT growth 1Y72.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.75%
EBIT Next 3Y29.81%
EBIT Next 5Y36.28%
FCF growth 1Y143.87%
FCF growth 3YN/A
FCF growth 5Y22.2%
OCF growth 1Y215.13%
OCF growth 3YN/A
OCF growth 5Y21.22%

ESTRIMA SPA / BIRO.MI Fundamental Analysis FAQ

What is the fundamental rating for BIRO stock?

ChartMill assigns a fundamental rating of 2 / 10 to BIRO.MI.


Can you provide the valuation status for ESTRIMA SPA?

ChartMill assigns a valuation rating of 2 / 10 to ESTRIMA SPA (BIRO.MI). This can be considered as Overvalued.


Can you provide the profitability details for ESTRIMA SPA?

ESTRIMA SPA (BIRO.MI) has a profitability rating of 1 / 10.


How financially healthy is ESTRIMA SPA?

The financial health rating of ESTRIMA SPA (BIRO.MI) is 3 / 10.


Can you provide the dividend sustainability for BIRO stock?

The dividend rating of ESTRIMA SPA (BIRO.MI) is 0 / 10 and the dividend payout ratio is -0.03%.